EJNMMI Research

Table 3 Effective doses in measured target organs

From: First evaluation of PET-based human biodistribution and radiation dosimetry of ¹¹C-BU99008, a tracer for imaging the imidazoline₂ binding site

Target organ	Mean absorbed dose (mGy/MBq)	Standard deviation (mGy/MBq)
Adrenals	0.008	0.003
Brain	0.008	0.001
Breasts^a	0.002	0.000
Gallbladder wall	0.006	0.001
LLI wall	0.003	0.000
Small intestine	0.005	0.001
Stomach wall	0.008	0.001
ULI wall	0.004	0.000
Heart wall	0.028	0.002
Kidneys	0.026	0.005
Liver	0.013	0.003
Lungs	0.015	0.002
Muscle	0.002	0.000
Ovaries^b	0.002	0.000
Pancreas	0.009	0.001
Red marrow	0.002	0.000
Osteogenic cells	0.003	0.001
Skin	0.001	0.000
Spleen	0.009	0.004
Testes	0.001	0.000
Thymus	0.003	0.000
Thyroid	0.006	0.001
Urinary bladder wall	0.002	0.000
Uterus^b	0.002	0.000
Total body	0.003	0.000

Data are mGy/MBq (mean ± SD, n = 4)
^aDoses are for male breast only, and may be different for female breasts
^bDoses to uterus and ovaries are based on doses from other source organs only

Back to article page